3rd Quarter - Report

FAEGRE DRINKER BIDDLE & REATH LLP for NATIONAL ASSOCIATION OF BOARDS OF PHARMACY

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs; COVID-19 response; H.R. 2482, S. 2074 - Mainstreaming Addiction Treatment Act; opposing prescription drug importation

LobbyistCovered position, as disclosed
LIBBY BANEY BURSTEIN —
MEGAN SUSSMAN HERBER Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Doris Matsui (D-CA)
BEENA S. PATEL —
SARAH-LLOYD STEVENSON Legislative Assistant, Sen. Roger Wicker (R-MS); Policy Advisor, HHS Office of the Secretary; Policy Advisor, Executive Office of the President (No lobbying of Executive Branch officials)

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2482 (116th), S. 2074 (116th)

Pharmacy PHA

Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs; COVID-19 response; H.R. 2482, S. 2074 - Mainstreaming Addiction Treatment Act; opposing prescription drug importation

LobbyistCovered position, as disclosed
LIBBY BANEY BURSTEIN —
MEGAN SUSSMAN HERBER Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Doris Matsui (D-CA)
BEENA S. PATEL —
SARAH-LLOYD STEVENSON Legislative Assistant, Sen. Roger Wicker (R-MS); Policy Advisor, HHS Office of the Secretary; Policy Advisor, Executive Office of the President (No lobbying of Executive Branch officials)

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2482 (116th), S. 2074 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.